Charles Kline | Associate Vice President
Merck

Charles Kline, Associate Vice President, Merck

A passionate believer in science and the value vaccines bring to society, Charles has supported all phases of vaccine development and commercial activities for bacterial, viral, recombinant, and conjugated vaccines, as well as mRNA programs in development.  Charles leads a team of talented Reg CMC scientists who are charged with expanding capacity for approved products and bringing exciting new products to patients globally.

Appearances:



Main Conference Day 2 - 10th March @ 16:40

Manufacturing and Regulatory Considerations for Personalized Cancer Vaccines

Main Conference Day 2 - 10th March @ 17:10

Panel: Process and Analytical Innovation for Access

last published: 16/Nov/26 13:20 GMT
last published: 16/Nov/26 13:20 GMT

back to speakers